Evidence map›Paper›PMID 30403799›Full record

SynthesisJournal of the National Cancer Institute2018

Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review.

Helena Carreira, Rachael Williams, Martin Müller, Rhea Harewood, Susannah Stanway, Krishnan Bhaskaran

Erratum issued 2 registry-linked trialsOpen access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of the National Cancer Institute, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 227 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 15 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05704855 nacompletednot on this mapstarted 2023, after this paper: background citation

A Remotely-Delivered, Combined Exercise Training Program for Cognitive Function in Women Living With and Beyond Breast Cancer: A Feasibility Study

TypeinterventionalSponsorUniversity of TorontoRan2023 to 2023Enrolled21ConditionsBreast CancerArmsCombined Exercise + Behavioural Counselling, Active Control
NCT05732064 phase4completednot on this mapstarted 2023, after this paper: background citation

Effects of Low-dose Dexmedetomidine-esketamine Combined Nasal Administration at Night on Perioperative Sleep Quality in Breast Cancer Patients: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorPeking University First HospitalRan2023 to 2025Enrolled180ConditionsBreast Cancer, Perioperative Period, Dexmedetomidine, EsketamineArmsDexmedetomidine, Esketamine, Normal saline
3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 15 syntheses or guidelines pooled it, 394 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Sexual dysfunction in women with breast cancer: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Psychosocial experiences of breast cancer survivors: a meta-review.Journal of cancer survivorship : research and practice · 2024
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Sexual Dysfunction in Women with Cancer: A Systematic Review of Longitudinal Studies.International journal of environmental research and public health · 2022
    Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Helena CarreiraDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Rachael WilliamsClinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency, London, UK.
Martin MüllerDepartment of Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Rhea HarewoodDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Susannah StanwayDepartment of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey, UK.
Krishnan BhaskaranDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBClinical Practice Research Datalink · GBRoyal Marsden NHS Foundation Trust · GBUniversity of Bern · CH

Funding

Medical Research Council MR/M016234/1Wellcome TrustWellcome Trust 107731/Z/15/Z
6 · The paper itself

Abstract

Background: We aimed to systematically review the evidence on adverse mental health outcomes in breast cancer survivors (≥1 year) compared with women with no history of cancer. Methods: Studies were identified by searching MEDLINE, PsycINFO, the Cumulative Index to Nursing and Allied Health Literature, and the Social Sciences Citation Index, and through backward citation tracking. Two researchers selected the studies, extracted data, and assessed the risk of bias. Results: Sixty studies were included. Of 38 studies of depression, 33 observed more depression in breast cancer survivors; this was statistically significant in 19 studies overall, including six of seven where depression was ascertained clinically, three of four studies of antidepressants, and 13 of 31 that quantified depressive symptoms. Of 21 studies of anxiety, 17 observed more anxiety in breast cancer survivors, statistically significant in 11 studies overall, including two of four with clinical/prescription-based outcomes, and in eight of 17 of anxiety symptoms. Breast cancer survivors also had statistically significantly increased symptoms/frequency of neurocognitive dysfunction (18 of 24 studies), sexual dysfunctions (5 of 6 studies), sleep disturbance (5 of 5 studies), stress-related disorders/PTSD (2 of 3 studies), suicide (2 of 2 studies), somatisation (2 of 2 studies), and bipolar and obsessive-compulsive disorders (1 of 1 study each). Studies were heterogeneous in terms of participants' characteristics, time since diagnosis, ascertainment of outcomes, and measures reported. Approximately one-half of the studies were at high risk of selection bias and confounding by socio-economic status. Conclusions: There is compelling evidence of an increased risk of anxiety, depression and suicide, and neurocognitive and sexual dysfunctions in breast cancer survivors compared with women with no prior cancer. This information can be used to support evidence-based prevention and management strategies. Further population-based and longitudinal research would help to better characterize these associations.

Indexed as

Cancer SurvivorsMental HealthSurvivorshipAnxietyBreast NeoplasmsCognitive DysfunctionDepressionHumansOutcome Assessment, Health CarePublication Bias

Identifiers

PMID30403799
PMCPMC6292797
OpenAlexW2900208351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.